Cosibelimab
Malignant Mesothelioma, Advanced
Checkpoint Therapeutics, Inc.Phase 1
—
Rating in progress
Cosibelimab in Malignant Mesothelioma, Advanced is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active